Addex Therapeutics Cash from Financing (TTM) Trends

Addex Therapeutics Ltd (ADXN)

15.55 -3.19 (-17.02%) USD | NASDAQ | Apr 24, 16:00

15.91 +0.36 (+2.32%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	5.863M
September 30, 2023	5.893M
June 30, 2023	10.33M
March 31, 2023	5.170M
December 31, 2022	3.253M
September 30, 2022	12.35M
June 30, 2022	7.846M
March 31, 2022	7.421M
December 31, 2021	17.95M

Date	Value
September 30, 2021	9.514M
June 30, 2021	9.564M
March 31, 2021	9.987M
December 31, 2020	0.0495M
September 30, 2020	-0.571M
June 30, 2020	-0.5434M
March 31, 2020	-0.5704M
December 31, 2019	-0.4667M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.571M

Minimum

Sep 2020

17.95M

Maximum

Dec 2021

6.061M

Average

5.893M

Median

Sep 2023

Cash from Financing (TTM) Benchmarks